Agency Information Collection Activities Comment Request, 18655-18656 [2024-05446]
Download as PDF
Federal Register / Vol. 89, No. 51 / Thursday, March 14, 2024 / Notices
Send comments to Carlos Graham,
SAMHSA Reports Clearance Officer,
5600 Fisher Lane, Room 15E57A,
Rockville, MD 20852 OR email him a
copy at carlos.graham@samhsa.hhs.gov.
Written comments should be received
by May 13, 2024.
Alicia Broadus,
Public Health Advisor.
[FR Doc. 2024–05444 Filed 3–13–24; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities Comment Request
ddrumheller on DSK120RN23PROD with NOTICES1
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer at (240) 276–
0361.
Comments are invited on: (a) whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Drug and Alcohol
Warning Network (DAWN) (OMB No.
0930–0078)—Reinstatement With
Change
Under the Public Health Service Act
(42 U.S.C. 290aa–4), SAMHSA is
authorized to collect data on the number
of individuals admitted to the
emergency rooms of hospitals as a result
of the abuse of alcohol or other drugs.
DAWN is a nationwide public health
surveillance system to improve hospital
emergency department (ED) monitoring
of substance use-related visits. It
captures data on ED visits related to
recent substance use and misuse
VerDate Sep<11>2014
16:47 Mar 13, 2024
Jkt 262001
directly from the electronic health
records (EHR) of participating hospitals.
The new DAWN helps SAMHSA and
public health professionals, clinicians,
and policymakers respond effectively to
the opioid and substance misuse crisis
in the United States.
SAMHSA is requesting OMB approval
of reinstatement with change of the
DAWN data collections, to include
following changes:
• Revise the data collection title to
‘‘Drug and Alcohol Warning Network’’,
replacing existing ‘abuse’ term and
including ‘‘alcohol’’ in the title.
• Remove drug-related death
investigation records review component
administered by state medical
examiners (MEs) and individual
medical examiners/coroners (ME/Cs).
• Revise data collection procedures
where participating hospitals can
choose the direct chart review option (at
the contractor’s operation center, homebased abstraction or on site at the
hospital). Hospitals will also have the
opportunity to select the machine
learning with natural language
processing (ML with NLP) option. The
option for hospitals to use their own
staff to abstract DAWN data as they did
in the legacy DAWN is no longer
offered.
• Revise the hospital selection design
of the ED component to a hybrid system
that combines sentinel hospitals and
probability-based selection of hospitals
from high priority suburban/rural areas
and from the remaining areas in the
United States.
• Change the reporting and
publication schedule to further increase
the timeliness of the new DAWN data
availability and delivery to SAMHSA.
The new DAWN data are collected on
an ongoing basis and could be available
to SAMHSA on demand. The new
DAWN data are delivered to SAMHSA
and available for analysis at a more
frequent intervals than the legacy
DAWN.
• Propose following changes to the
ED Case Report Form:
Æ Add ‘‘Center for Behavioral Health
Statistics and Quality’’ to specify the
center responsible for DAWN data
collection.
Æ Revise the data collection title to
‘‘Drug and Alcohol Warning Network’’
from ‘‘Drug Abuse Warning Network.’’
Æ Replace prior ‘‘Facility’’ data field
title with ‘‘Hospital Emergency
Department ID’’ to provide more precise
description and ID number of the
DAWN participating hospitals.
Æ Q3 ‘‘Age’’: replace prior option of
‘‘less than 1 year’’ with two detailed
options of ‘‘4 weeks (28 days) or
younger’’ and ‘‘Between 4 weeks and
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
18655
one year old (>4 weeks, <1 year)’’ to
enable new identification of neonatal
substance issues.
Æ Q4 ‘‘County of Residence’’: revise
data field title from prior ‘‘patient’s
home zip code’’ and add more accurate
description on what data to be collected
and clarify the purpose of data
collection. Add new ‘‘Unable to
determine county’’ option to improve
data accuracy and account for
geographical variation.
Æ Q6 ‘‘Gender Identity’’ and Q7
‘‘Sexual Orientation’’: added to provide
inclusive measures and to align with
SAMHSA’s efforts in enhancing
behavioral health equities among
diverse populations.
Æ Q8 ‘‘Ethnicity’’ and Q9 ‘‘Race’’:
revise prior data field ‘‘Race/Ethnicity’’
to align with OMB 1997 Standards for
Maintaining, Collecting, And Presenting
Federal Data on Race and Ethnicity
(Statistical Policy Directive No. 15) and
to improve data accuracy and
comprehensiveness.
Æ Q10 ‘‘Case Description’’: replace
the word ‘‘drug(s)’’ with ‘‘substance(s)’’
to clarify that the DAWN collects data
on all substances including alcohol.
Add new instruction language of ‘‘Do
not include information that could
identify the patient or hospital’’ to
provide clear instruction and specify the
importance of patient and hospital
privacy protection.
Æ Q11 ‘‘Substance(s) Involved and
Route of Administration’’: add two new
options of ‘‘transdermal’’ and ‘‘vaped’’
to improve the comprehensiveness of
the list on how substance is
administered by the patient. Remove
‘‘Mark if confirmed by toxicology test’’
and ‘‘alcohol involved?’’
Æ Q12 ‘‘Diagnosis’’: change the
question order and move the data field
after Q11. Revise prior instruction of
‘‘list up to 4 diagnoses’’ to ‘‘list all
diagnoses’’ to enhances new DAWN’s
ability to identify novel drug, drug
trends, and drug outbreaks.
Æ Q13 ‘‘Type of Case’’: remove
instruction language of ‘‘using the
decision tree.’’ Revise the existing
option of ‘‘seeking detox’’ to ‘‘seeking
detox and/or substance abuse treatment
only’’ and remove age restriction for
‘‘Alcohol only’’ option to include cases
involving alcohol as the only substance
of all ages.
Æ Q14, Q15, and Q16 ‘‘Was naloxone/
buprenorphine/Methadone
administered to the patient in the ED’’:
added to capture new data on the
implementation of medication-assisted
treatment for opioid use disorder in the
emergency department setting and
understand why buprenorphine and
methadone is administered.
E:\FR\FM\14MRN1.SGM
14MRN1
18656
Federal Register / Vol. 89, No. 51 / Thursday, March 14, 2024 / Notices
Æ Q17 ‘‘Disposition’’: add new
options and re-categorize disposition to
improve data accuracy and
comprehensiveness and better
understand where the patient went after
their ED visit.
Information collection activities
• Proposes a new Activity Report
From to be submitted by the abstractors
to collect information on the date of ED
visits the abstractor has reviewed,
counts of ED visits for that date, number
of records reviewed, and number of left
without being seen (LWBS) visits for the
ED visit date if participating hospitals
choose the direct chart review option.
The estimated annual burden for the
DAWN data collection is as follows:
Number of
respondents
Hours per
response
(in hours)
Responses per
respondent
Total
responses
I
Total
burden
hours
I
Average
hourly
wage
I
Total
annual
cost
Setting Up Activities *
Initial outreach and recruitment (all hospitals)
ED record provision setting up (direct chart review) .............................................................
ED record provision setting up (ML with NLP)
143
1
143
81.50
58
85
1
1
58
85
5.25
36.00
11,655
305
3,060
I
I
$48.72
$567,807
26.71
26.71
8,133
81,733
26.71
26.71
2,324
13,622
Ongoing Maintenance Activities
Ongoing Maintenance (direct chart review) .....
Ongoing Maintenance (ML with NLP) .............
58
85
1
1
58
85
1.50
6.00
Totals ........................................................
......................
..........................
..................
....................
87
510
I
15,616
I
..............
I
673,619
* Setting up activities will be conducted once.
Send comments to Carlos Graham,
SAMHSA Reports Clearance Officer,
5600 Fisher Lane, Room 15E57A,
Rockville, MD 20852 OR email him a
copy at Carlos.Graham@
samhsa.hhs.gov. Written comments
should be received by May 13, 2024.
Alicia Broadus,
Public Health Advisor.
[FR Doc. 2024–05446 Filed 3–13–24; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2024–0002; Internal
Agency Docket No. FEMA–B–2417]
Changes in Flood Hazard
Determinations
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Notice.
AGENCY:
This notice lists communities
where the addition or modification of
Base Flood Elevations (BFEs), base flood
depths, Special Flood Hazard Area
(SFHA) boundaries or zone
designations, or the regulatory floodway
(hereinafter referred to as flood hazard
determinations), as shown on the Flood
Insurance Rate Maps (FIRMs), and
where applicable, in the supporting
Flood Insurance Study (FIS) reports,
prepared by the Federal Emergency
Management Agency (FEMA) for each
community, is appropriate because of
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:47 Mar 13, 2024
Jkt 262001
new scientific or technical data. The
FIRM, and where applicable, portions of
the FIS report, have been revised to
reflect these flood hazard
determinations through issuance of a
Letter of Map Revision (LOMR), in
accordance with Federal Regulations.
The currently effective community
number is shown in the table below and
must be used for all new policies and
renewals.
DATES: These flood hazard
determinations will be finalized on the
dates listed in the table below and
revise the FIRM panels and FIS report
in effect prior to this determination for
the listed communities.
From the date of the second
publication of notification of these
changes in a newspaper of local
circulation, any person has 90 days in
which to request through the
community that the Deputy Associate
Administrator for Insurance and
Mitigation reconsider the changes. The
flood hazard determination information
may be changed during the 90-day
period.
ADDRESSES: The affected communities
are listed in the table below. Revised
flood hazard information for each
community is available for inspection at
both the online location and the
respective community map repository
address listed in the table below.
Additionally, the current effective FIRM
and FIS report for each community are
accessible online through the FEMA
Map Service Center at https://
msc.fema.gov for comparison.
Submit comments and/or appeals to
the Chief Executive Officer of the
community as listed in the table below.
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Rick
Sacbibit, Chief, Engineering Services
Branch, Federal Insurance and
Mitigation Administration, FEMA, 400
C Street SW, Washington, DC 20472,
(202) 646–7659, or (email)
patrick.sacbibit@fema.dhs.gov; or visit
the FEMA Mapping and Insurance
eXchange (FMIX) online at https://
www.floodmaps.fema.gov/fhm/fmx_
main.html.
FOR FURTHER INFORMATION CONTACT:
The
specific flood hazard determinations are
not described for each community in
this notice. However, the online
location and local community map
repository address where the flood
hazard determination information is
available for inspection is provided.
Any request for reconsideration of
flood hazard determinations must be
submitted to the Chief Executive Officer
of the community as listed in the table
below.
The modifications are made pursuant
to section 201 of the Flood Disaster
Protection Act of 1973, 42 U.S.C. 4105,
and are in accordance with the National
Flood Insurance Act of 1968, 42 U.S.C.
4001 et seq., and with 44 CFR part 65.
The FIRM and FIS report are the basis
of the floodplain management measures
that the community is required either to
adopt or to show evidence of having in
effect in order to qualify or remain
qualified for participation in the
National Flood Insurance Program
(NFIP).
These flood hazard determinations,
together with the floodplain
management criteria required by 44 CFR
60.3, are the minimum that are required.
They should not be construed to mean
SUPPLEMENTARY INFORMATION:
E:\FR\FM\14MRN1.SGM
14MRN1
Agencies
[Federal Register Volume 89, Number 51 (Thursday, March 14, 2024)]
[Notices]
[Pages 18655-18656]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05446]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities Comment Request
In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer at (240) 276-0361.
Comments are invited on: (a) whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Drug and Alcohol Warning Network (DAWN) (OMB No.
0930-0078)--Reinstatement With Change
Under the Public Health Service Act (42 U.S.C. 290aa-4), SAMHSA is
authorized to collect data on the number of individuals admitted to the
emergency rooms of hospitals as a result of the abuse of alcohol or
other drugs. DAWN is a nationwide public health surveillance system to
improve hospital emergency department (ED) monitoring of substance use-
related visits. It captures data on ED visits related to recent
substance use and misuse directly from the electronic health records
(EHR) of participating hospitals. The new DAWN helps SAMHSA and public
health professionals, clinicians, and policymakers respond effectively
to the opioid and substance misuse crisis in the United States.
SAMHSA is requesting OMB approval of reinstatement with change of
the DAWN data collections, to include following changes:
Revise the data collection title to ``Drug and Alcohol
Warning Network'', replacing existing `abuse' term and including
``alcohol'' in the title.
Remove drug-related death investigation records review
component administered by state medical examiners (MEs) and individual
medical examiners/coroners (ME/Cs).
Revise data collection procedures where participating
hospitals can choose the direct chart review option (at the
contractor's operation center, home-based abstraction or on site at the
hospital). Hospitals will also have the opportunity to select the
machine learning with natural language processing (ML with NLP) option.
The option for hospitals to use their own staff to abstract DAWN data
as they did in the legacy DAWN is no longer offered.
Revise the hospital selection design of the ED component
to a hybrid system that combines sentinel hospitals and probability-
based selection of hospitals from high priority suburban/rural areas
and from the remaining areas in the United States.
Change the reporting and publication schedule to further
increase the timeliness of the new DAWN data availability and delivery
to SAMHSA. The new DAWN data are collected on an ongoing basis and
could be available to SAMHSA on demand. The new DAWN data are delivered
to SAMHSA and available for analysis at a more frequent intervals than
the legacy DAWN.
Propose following changes to the ED Case Report Form:
[cir] Add ``Center for Behavioral Health Statistics and Quality''
to specify the center responsible for DAWN data collection.
[cir] Revise the data collection title to ``Drug and Alcohol
Warning Network'' from ``Drug Abuse Warning Network.''
[cir] Replace prior ``Facility'' data field title with ``Hospital
Emergency Department ID'' to provide more precise description and ID
number of the DAWN participating hospitals.
[cir] Q3 ``Age'': replace prior option of ``less than 1 year'' with
two detailed options of ``4 weeks (28 days) or younger'' and ``Between
4 weeks and one year old (>4 weeks, <1 year)'' to enable new
identification of neonatal substance issues.
[cir] Q4 ``County of Residence'': revise data field title from
prior ``patient's home zip code'' and add more accurate description on
what data to be collected and clarify the purpose of data collection.
Add new ``Unable to determine county'' option to improve data accuracy
and account for geographical variation.
[cir] Q6 ``Gender Identity'' and Q7 ``Sexual Orientation'': added
to provide inclusive measures and to align with SAMHSA's efforts in
enhancing behavioral health equities among diverse populations.
[cir] Q8 ``Ethnicity'' and Q9 ``Race'': revise prior data field
``Race/Ethnicity'' to align with OMB 1997 Standards for Maintaining,
Collecting, And Presenting Federal Data on Race and Ethnicity
(Statistical Policy Directive No. 15) and to improve data accuracy and
comprehensiveness.
[cir] Q10 ``Case Description'': replace the word ``drug(s)'' with
``substance(s)'' to clarify that the DAWN collects data on all
substances including alcohol. Add new instruction language of ``Do not
include information that could identify the patient or hospital'' to
provide clear instruction and specify the importance of patient and
hospital privacy protection.
[cir] Q11 ``Substance(s) Involved and Route of Administration'':
add two new options of ``transdermal'' and ``vaped'' to improve the
comprehensiveness of the list on how substance is administered by the
patient. Remove ``Mark if confirmed by toxicology test'' and ``alcohol
involved?''
[cir] Q12 ``Diagnosis'': change the question order and move the
data field after Q11. Revise prior instruction of ``list up to 4
diagnoses'' to ``list all diagnoses'' to enhances new DAWN's ability to
identify novel drug, drug trends, and drug outbreaks.
[cir] Q13 ``Type of Case'': remove instruction language of ``using
the decision tree.'' Revise the existing option of ``seeking detox'' to
``seeking detox and/or substance abuse treatment only'' and remove age
restriction for ``Alcohol only'' option to include cases involving
alcohol as the only substance of all ages.
[cir] Q14, Q15, and Q16 ``Was naloxone/buprenorphine/Methadone
administered to the patient in the ED'': added to capture new data on
the implementation of medication-assisted treatment for opioid use
disorder in the emergency department setting and understand why
buprenorphine and methadone is administered.
[[Page 18656]]
[cir] Q17 ``Disposition'': add new options and re-categorize
disposition to improve data accuracy and comprehensiveness and better
understand where the patient went after their ED visit.
Proposes a new Activity Report From to be submitted by the
abstractors to collect information on the date of ED visits the
abstractor has reviewed, counts of ED visits for that date, number of
records reviewed, and number of left without being seen (LWBS) visits
for the ED visit date if participating hospitals choose the direct
chart review option.
The estimated annual burden for the DAWN data collection is as
follows:
--------------------------------------------------------------------------------------------------------------------------------------------------------
Hours per Total Average
Information collection activities Number of Responses per Total response burden hourly Total
respondents respondent responses (in hours) hours wage annual cost
--------------------------------------------------------------------------------------------------------------------------------------------------------
Setting Up Activities *
--------------------------------------------------------------------------------------------------------------------------------------------------------
Initial outreach and recruitment (all hospitals)................ 143 1 143 81.50 11,655 $48.72 $567,807
ED record provision setting up (direct chart review)............ 58 1 58 5.25 305 26.71 8,133
ED record provision setting up (ML with NLP).................... 85 1 85 36.00 3,060 26.71 81,733
--------------------------------------------------------------------------------------------------------------------------------------------------------
Ongoing Maintenance Activities
--------------------------------------------------------------------------------------------------------------------------------------------------------
Ongoing Maintenance (direct chart review)....................... 58 1 58 1.50 87 26.71 2,324
Ongoing Maintenance (ML with NLP)............................... 85 1 85 6.00 510 26.71 13,622
---------------------------------------------------------------------------------------
Totals...................................................... ............ ............... .......... ........... 15,616 ........ 673,619
--------------------------------------------------------------------------------------------------------------------------------------------------------
* Setting up activities will be conducted once.
Send comments to Carlos Graham, SAMHSA Reports Clearance Officer,
5600 Fisher Lane, Room 15E57A, Rockville, MD 20852 OR email him a copy
at [email protected]. Written comments should be received by
May 13, 2024.
Alicia Broadus,
Public Health Advisor.
[FR Doc. 2024-05446 Filed 3-13-24; 8:45 am]
BILLING CODE 4162-20-P